The Weekly Litigation News Digest is now live. Subscribe now

Sanofi competitive analysis

Loading summary...

Explore patent oppositions filed by Sanofi against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Bispecific Antigen Binding ConstructARGENX BVBAJul 23, 2025
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINEJul 22, 2025
High-Purity Peg Lipids And Uses ThereofMODERNAJun 24, 2025
Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein ConjugatesMERCK SHARP & DOHMEMar 18, 2025
Dosage Measurement Module On Injection PenELI LILLYMar 7, 2025
Nucleic Acid VaccinesMODERNAMar 3, 2025
Nucleic Acid VaccinesMODERNAMar 3, 2025
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNAFeb 28, 2025
Methods And Apparatus For Aspects Of A Dose Detection SystemELI LILLYNov 4, 2024
Compositions And Methods For Treating Cytokine-Related DisordersTHE CHILDRENS HOSPITAL OF PHILADELPHIAOct 23, 2024

Explore Sanofi's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Sep 3, 2025Lixisenatide Synthesis With Capping2
Jun 18, 2025Stabilization Of Vaccines By Lyophilization1
May 28, 2025Data Collection Device For Attachment To An Injection Device2
Apr 30, 2025Auto-Injector2
Dec 11, 2024A Device For Attachment To An Injection Device1
Oct 16, 2024Long - Acting Formulations Of Insulins1
Oct 9, 2024Autoinjector1
Jul 31, 2024Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist4
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist7
Feb 28, 2024Packaging Container1

Latest PTAB cases involving Sanofi

Discover the latest PTAB cases involving Sanofi, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 14, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Sanofi

IPR2019-01658Oct 7, 2019MYLAN PHARMACEUTICALSSANOFI AVENTIS DEUTSCHLANDInstitution Denied
IPR2019-00977May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00978May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00979May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDFinal Written Decision
IPR2019-00980May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00981May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00982May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-00987May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-01022May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other
IPR2019-01023May 2, 2019PFIZERSANOFI AVENTIS DEUTSCHLANDTerminated-Other

Peer Comparison New

IP litigation analysis comparing Sanofi with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SANOFI5923 - -
CUREVAC - 62 - 1
GLAXOSMITHKLINE29112812
MODERNA57542